Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Precancerous Conditions 3 Lung Neoplasms 3 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocytopenia 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms 1 Mesothelioma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1

Interventions

Cyclophosphamide 101 Etoposide 60 Carboplatin 55 Vincristine 51 Filgrastim 49 Topotecan 44 Temozolomide 44 Melphalan 44 Isotretinoin 44 Doxorubicin 44 Irinotecan 42 Cisplatin 35 3-Iodobenzylguanidine 34 Peripheral Blood Stem Cell Transplantation 31 dinutuximab 30 Granulocyte Colony-Stimulating Factor 30 Radiotherapy 29 sargramostim 28 Granulocyte-Macrophage Colony-Stimulating Factor 25 Busulfan 22 Magnetic Resonance Spectroscopy 19 aldesleukin 18 Thiotepa 18 fludarabine 17 Interleukin-2 17 humanized 3F8 anti-GD2 monoclonal antibody 16 etoposide phosphate 16 naxitamab 15 Ifosfamide 15 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Comparative Genomic Hybridization × Clear all

NCT01169376 2016-05-18

Biomarkers in Young Patients With Neuroblastoma

Children's Oncology Group

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡